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Disease management is a comprehensive, integrateaapprnach 
to care and reimbursement based on the natural course of a 
disease, with treatment designed to address an illness with 
maximum effectiveness and efficiency. 4 
B. General 
In the March, 1992 issue of the New England Journal of 
Medicine article by K. Weiss, et al., the costs of asthma, 
estimated to be $6 billion annually in the U.S., include drug 
therapy, hospitalization costs, visits with physicians, and 
detailed diagnostic tests. Other researchers have noted that 
asthma costs are heavily concentrated in a small portion of the 
affected population: 5% of the asthmatics account for 70% of 
the costs associated with the disease. 1 
The Weiss study pointed out that 43 % of the total system 
costs are associated with the disease on patients with out-of-
control cases: emergency room treatments, hospitalization, and 
death. An economic analysis in a sample population indicates 
that by managing the condition effectively through early 
intervention and prevention, a system wide savings of 25 % 
could be realized. 1 
The techniques that could be used to achieve these savings 
include patient education programs to ensure the proper use of 
steroids and physician education targeted at early identification 
and appropriate specialist referral. The program would satisfy 
both the clinical goal of long term control of the condition and 
the economic goal of cost containment. 4 
A number of healthcare delivery companies have realized that if 
costs are truly to be brought under control and better quality 
care is to be provided, a new paradigm is needed, one focused 
on market based system management oriented around 
particular diseases. Each disease has a distinctive pattern of 
cost elements, a different and varying pattern of cost 
occurrence during its course, and a unique range of available 
therapies and interventions. Accordingly, the building blocks 
for analyses and system design should be specific diseases. 2 
At the 1994 annual meeting of the National Wholesale 
Druggists' Association (NWDA), Thomas A. Moore of Procter & 
Gamble said that any new health care system will be measured 
in terms of the perceived value it gives to the eonsumer. 
Pharmacists have a major opportunity to serve the consumer by 
providing cognitive services. After a slow start, pharmacists 
are enlarging their role in that area through limited patient 
counseling and drug utilization review. Payers are going to 
start demanding cognitive services and are probably going to 
be willing to pay for them. Moore told NWDA wholesaler and 
manufacturer members that there are at least 2 key areas in 
which the drug industry can profit: prescription drugs and 
over-the-counter (OTC) drugs. More prescription drugs could 
mean less net cost to the system if enough cognitive services 
are delivered to make the products effective, and cost-
conscious managed care organizations would rather use 
consumer-purchased OTCs as a first line of therapy if 
possible. 10 
C. CLINICAL QUALITY 
Clinical quality has become, at least nominally, the basis upon 
which HMOs, other managed care plans, and employers are 
seeking to differentiate providers and to make purchasing 
decisions. For these criteria to be credible, it is important to 
establish the medical community's ability to measure and 
document quality objectively. Although significant strides in 
this direction have been made, we believe that the medical 
industry is still in the early stages of compiling and providing 
reliable information on clinical quality. 
Clinical quality consists of four components: 
1. Appropriateness of care, including compliance with 
practice guidelines 
2. Technical effectiveness, including measurable clinical 
outcomes. 
3. Functional outcomes, including patient satisfaction and 
whether the treatment accomplished its stated 
objectives. 
4. Efficiency (i.e., whether the appropriate clinical resources 
were used to achieve the desired result). 
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Gathering and formatting information to be used in establishing 
the criteria for evaluating clinical quality (and for its continuing 
measurement and dissemination) is a major undertaking that is 
becoming increasingly critical to the clinical management 
processes of integrated delivery systems. 




Some of the leading managed care companies in the U.S. are 
beginning to put a disease oriented approach in place. Some of 
the leaders are the Group Health Cooperative of Puget Sound 
with its Diabetes Roadmap effort in- conjunction with Eli Lilly 
and Boehringer Mannheim; Harvard Community Health Plan, 
with its algorithm approach to disease management; and Deere 
and Co., which is working with the Mayo Clinic on a disease-
management system for its employees. 4 
Pharmaceutical Industry RelationshiQ;° 
As noted in the Group Health Diabetes effort, the 
pharmaceutical industry has expanded its role into outcomes 
research through the rapid acquisitions recently of pharmacy 
benefit management companies (PBMs) whose services include 
claims processing and complete drug benefit administration. 
Reasons for the acquisitions include heavy price pressure from 
managed care organizations (MCOs) and Pharmacy Benefit 
Management organizations (PBMs), restrictive formularies of 
MCOs and PBMs, and access to the PBMs extensive pharmacy 
claims data which can be utilized for outcomes research to 
justify formulary decisions. 
"Closely tied with the focus on outcomes research is perhaps 
the most revolutionary concept emerging from vertical 
pharmaceutical integration: drug companies positioning 
themselves as disease management entities. The goal is to 
change the image of drug companies from sellers of pills to 
providers of patient care strategies. Because of the emphasis 
on correct and consistent drug usage, disease management 
initiatives predominantly target chronic conditions that have 
notoriously high non-compliance rates, such as diabetes, 
asthma, and hypertension. The theory behind drug company 
involvement in patient care strategies is that the pharmaceutical 
company understands the physiologic mechanisms through 
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C. 
which the disease operates and can take the talent, the 
knowledge, and the interaction between the scientist and the 
clinician and apply it to the management of the disease itself. " 3 
As an outgrowth of this movement, Pfizer and Value Health are 
collaborating on a joint venture in disease management. In 
addition, Merck, Smith Kline-Beecham, and Eli Lilly are ' all 
developing pharmaceutical care and disease management 
programs through their newly purchased PBM divisions. 
Cleveland Clinic 
Lessons learned from original case management efforts proved 
that multi-disciplinary groups could establish coordinated care 
tracks based on clinical judgments and statistical data. The 
CCTs serve as standards of care by identifying the specific 
sequence and timing of multiple interventions. Much of the 
early efforts concentrated on the 11 when" and 11how" of a 
particular intervention, and utilization review focused on 
reduction of length of stay and on system processes to ensure 
that the 11when" and 11how" occurred as defined. A criticism of 
this approach is that the appropriateness of the intervention 
may be overlooked. Therefore, a major focus of current work 
is to ensure that the most effective and efficient interventions 
are done. This has led to practice changes regarding drug and 
other therapies. Examples follow: 
1 . Intravenous human immune globulin has been removed 
from the autologous bone marrow protocol resulting in a 
$2,500 per patient cost savings. Additionally, oral 
aminocaproic has been introduced as a homegoing 
medication in the thrombocytopenic autologous bone 
marrow transplant population. 
2. Reassessment of proper time for nasogastric (NG) tube 
removal in the colorectal population has allowed 80 
percent of the population to have their NG tube removed 
one day sooner than established protocol. This allows 
for earlier nutritional decisions and supports patient 
recovery. 
3. Radical prostatectomy patients who develop urine leaks 
(approximately 10 percent of the population) are 
discharged to home with drains and instructions, or 
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referred to home care services. These activities allow for 
better utilization of resources. 
Following the principles of vertical integration (mainly the 
coordination of service lines with the different stages of 
production) the nursing case management process has 
broadened its definition of episode of illness from tt:le hospital 
component to include all CCF care interactions. Nurses 
contribute to patient outcomes in every aspect of clinical care. 
Nursing is a partner in maintaining and improving the Cleveland 
Clinic Foundation's efficiency. Efficiency, as a vertical 
integration motivator, focuses on production costs, contractual 
costs, and information economics (Arndt & Bigelow, 1992). 
Alternate site care coordination is an example of efficiency. 
This service coordinates care for subacute skilled and home 
skilled services, home infusion therapy, home hospice care, and 
home respiratory care. The subacute care program, directed by 
nurses, offers short-term 24 hour skilled nursing care to 
patients who do not need the acute care resources of the 
hospital. Skilled nursing care facilities (SNF) with specialized 
subacute units are contracted to provide care. Selected SNFs 
,meet staffing requirements, possess the needed clinical 
expertise and agree to follow the CCF established medical 
programs and procedures for care. This program therefore 
provides for full continuity of care and streamlines the 
transition process of patients to appropriate post- discharge 
care. The economics translate into tighter links between CCF 
and SNFs with the transfer and use of information between 
different levels of care. This program is one example of what 
Conrad & Bigelow ( 1990) identify as finding synergy's between 
different levels of care processes. 
The discharge planning function of the case manager, coupled 
with the alternate site care coordination ensures care 
coordination post-discharge. Expansion of the practice and 
principles of nursing case management into the outpatient 
clinics is also presently evolving. By its very structure, the CCF 
has linkages between inpatient and outpatient facilities, thereby 
eliminating many production and transaction costs. The 
introduction of nursing case management in the outpatient 
setting is specific to those patients who require a clinic visit 
beyond routine return appointments following hospitalization. 
This unplanned visit, viewed as a variance, is investigated by 
the case manager to determine cause. If provider issues are 
the cause (e.g. inadequate patient education regarding 
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medications), a continuous quality improvement process will be 
initiated to identify factors contributing to the variance. Finally, 
aggregate data analysis allows for CCT revisions. 
Additionally, the outpatient clinic nurse will assess whether 
attainment of the discharge criteria have been sustained after 
the patient is discharged. These data assist in examining ·the 
episode of care for a disease condition rather than for analysis 
of a specific setting. Coordinated care tracks, which represent 
the trajectory of an illness or disease condition, and then be 
developed. These CCTs can assist in preventing the underuse 
and overuse of resources. Additionally, the data serve as 
measures of previous hospitalization and its effectiveness. 
111. MEASURING QUALITY OF CARE IN PHYSICIANS OFFICES. 6 
A. General 
B. 
As the utilization of medical services has increased, the cost of 
medical services has also increased. As attempts are made to 
reduce costs, the concern about quality of care increases. 
Utilization of Medical Services 
The appropriate utilization of medical services is controversial 
because conclusive information on prevention and treatment of 
disease does not exist. Therefore, much of what is done in 
medicine is based on incomplete information. For example, the 
treatment of a sore throat, may generally involve culture of the 
throat and antibiotics. Specifically when to culture and which 
antibiotic to use will vary from physician to physician and, 
frequently, from patient to patient. 
Also, we know that patients may have different concerns 
regarding their health than do physicians or insurers of health 
care. For example, diminishing the symptoms of a sore throat 
is usually of primary importance to patients. For physicians, 
preventing the occurrence of rheumatic fever may be the top 
priority. Finally, for insurers of health care, limiting the cost of 
medical services for minor conditions such as sore throat may 
be of primary importance. Our current, knowledge of health 
care presents us with incomplete data on which to determine 
appropriate utilization of medical services, and therefore, 
evaluate the appropriateness of medical care. 
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In light of these differences, there are two immediate objectives 
of quality assurance. The first is to demonstrate and document 
good quality be providing findings and explaining methods to 
those who use and to those who pay for medical services. The 
second objective is to provide for continuous improvement in 
quality by those who provide medical services. 
A model is needed for physicians offices that defines quality of 
care, recognizes the lack of complete information on the 
prevention and treatment of disease, accommodates the 
controversy on utilization of medical services, and provides 
ongoing cost savings. Such a model does exist. In the health 
care industry physicians provide quality medical care when they 
meet the needs of their customers, their patients. These needs 
are universal and easily defined; they are what each of us 
desire for ourselves and those we love: competence, 
commitment, convenience, courtesy, and compassion. To 
date, systems that have attempted to measure quality of 
medical care have focused on professional competence only. 
The other four needs have been assumed to be present and 
have not been measured directly. To be effective, a quality 
assurance system should be concerned with all five patient 
needs. 
There are three components to examine when assessing 
performance structure, process, and outcome. To examine the 
structure under which good medical care is provided, an 
evaluation of the training, credentials, experience, equipment, 
and facilities required to provide medical care must be made. 
These parameters are measured by reviewing medical staff 
files, m medial school and specialty certifications, and 
performing site visits and inspections 
The second component, the process of providing medical care, 
can be evaluated by looking at the decision-making, testing, 
procedures, and treatments that comprise medical care. These 
parameters are measured from billing data, medical chart 
review, patient questionnaires, simulated patient encounters, 
and patient interviews. 
Finally, the outcome of the medical care provided must be 
examined. Many outcomes are relevant to quality 
measurement such as the incidence of postoperative 
infections and anesthetic complications. Many other outcome 
measures have limitations in evaluating the performance of 
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individual physicians. For example, many bad outcomes are 
expected to occur infrequently, after long delays, or not at all 
despite poor care. Thus, evaluating whether the process of 
medical care that has been accepted as essential to the 
prevention of a specific outcome has been followed is, in many 
cases, a better measure of quality than is the nonoccurrence of 
the outcome. 
C. Use of Standards 
Consideration should be given to selecting standards that meet 
the test of acceptability, specificity, and measurability. 
Acceptability is achieved by selecting standards from those that 
are published by recognized authorities and accepted by most 
physicians. Organizations such as the United States Preventive 
Services Task Force, the Centers for Disease Control, the 
National Committee for Quality Assurance, and the Joint 
Commission of Accreditation of Healthcare Organizations have 
published recommendations on medical care. Controversial 
standards should be avoided and individual organizations or 
groups should not attempt to develop their own standards. 
Specificity is achieved by selecting explicit standards. Explicit 
standards have specific instructions that lessen the need for 
judgment by individuals and, therefore, can avoid bias. For 
example, 11uses consultants appropriately" appears to be a 
good question and is a commonly used standard. 
(Unfortunately, any time the word 11appropriate 1' in a standard 
an 11expert" is required to determine 11appropriateness." An 
1 expert I tends to assess performance from the perspective 
of the impact of the standard on the patient population as a 
whole rather than from the perspective of the consequences for 
an individual patient. Practicing physicians judiciously reverse 
these priorities. In addition, because evaluating standards 
requires medical judgment, assessments that require 11experts" 
are expensive, cannot be done cost-effectively, and produce 
inconsistent findings. 
Measurability is achieved by selecting standards that can be 
accurately measured in a cost-effective way. 11 Are office hours 
convenient?" is an important question to ask when evaluating 
the accessibility of facilities and services. This can accurately 
and inexpensively be answered by means of a patient 
questionnaire. 
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D. Corrective Actions To Improve Quality of Care. 
Corrective actions should be aimed at making it easier for 
physicians to comply with the selected standards. Problems in 
quality are not generally caused by incompetence or poor 
intentions on the part of physicians. Most physicians are highly 
motivated. Performance cannot be changed through- attempts 
to increase motivation. Instead, evaluation of quality must be 
translated into pragmatic tools to influence directly the delivery 
of care. 
The quality of care is determined by individual physicians 
making decisions on individual patients. To impact quality, 
information must be provided to affect decisions at this level. 
The quality assurance information developed from assessing 
performance should be reviewed with individual physicians. 
Areas of strength and areas of weakness should be identified. 
Incentives for improvement and the means to accomplish it 
should be discussed and agreed upon. 
If problems are common to most physicians within a group, a 
system change can improve results. For example, it is unusual 
to find an organized method of recording adult immunizations 
when auditing medical records of primary care physicians. If a 
group has low scores with regard to adult immunizations, a 
simple form for recording immunization of adults provides a 
convenient reminder to physicians of this standard. 
If problems are common to only a few physicians, awareness, 
education, or other individual consequences may be required. 
Often the knowledge that performance is variant from that of 
others causes change in behavior. It is a mistake to believe 
that there is always a "right" answer; as medical care changes, 
the "right" answer also changes. Over time, accepted 
practices shown to be ineffective are replaced by newer ones 
believed to be effective. 
The corrective action must be supportive of the individual 
physician. Threatening information becomes information to be 
ignored or defended against. More importantly, supportive 
information becomes information that can modify decisions and 
improve medical care. Low scores do not necessarily indicate 
bead physicians; they indicate problems that food physicians 
will correct. 
9 





Practice parameters are strategies for patient management, 
developed to assist physicians in clinical decision making. 
Practice parameters include guidelines, standards, -and other 
patient management strategies. 
History 
As the demonstrated usefulness of these patient management 
strategies has grown, interest in the development of practice 
parameters has grown. In the 1930's, only one physician 
organization was developing practice parameters. By 1980, 
eight physician organizations were actively engaged in their 
development. As of 1991, at least 32 physician organizations 
have developed practice parameters, and many other physician 
organizations are planning to do so. In total, over 1. 100 
practice parameters have been developed by physician 
organizations and others. In addition, at the beginning of 
1991, over 1 50 practice parameters were under development. 
The medical profession has been the primary force in the 
development of practice parameters, although other 
organizations, such as the federal government, have recently 
initiated activities in this area. 
Application of Practice Parameters 
The use of practice parameters has been helpful in several 
areas such as: 
1 . Appropriateness of Care 
2. Risk Management 
3. Credentialling 
4. Quality Assurance 
5. Utilization Review 
6. Payment Coverage Decisions 
Medical Review System 11 
In response to calls for value in health care, managed care 
organizations are seeking ways to manage treatment on the 
front end. The transition from retrospective utilization review 
10 
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to prospective decision making using practice guidelines is 
typified by Blue Plus experience reviewing appropriateness of 
medical procedures. In its program, specialists recommending 
surgery must run their patient's clinical indications through a 
Medical Review System, which uses an algorithm to review the 
criteria. If the computer rejects the information, it is referred to 
a physician who conducts peer review. If the procedure later 
fails at an appeal level, Blue Plus will not pay for it. According 
to Blue Plus' Mark Banks, the program has been successful in 
reducing the number of inappropriate procedures. Instead of 
reviewing appropriateness, United Healthcare Corporation, of 
Minneapolis, is targeting disease prevention. In developing 
practice guidelines, Winston-Salem Health Care Plan Inc. uses 
practice parameters written by the medical specialties as a 
starting point. 
E. Blue Cross and Blue Shield of Illinois 12 
In an interview, Blue Cross and Blue Shield of Illinois medical 
director Arnold Widen discussed the practice guidelines that 
Blue Cross and Blue Shield is including in the contracts of some 
specialists who are applying to join its new point-of-service 
product, Managed Care Network Preferred (MCNP). 
Introduction of the practice guidelines in fall 1993 brought 
swift objections from organized medicine, particularly the AMA 
and the Illinois State Medical Society. Though Blue Cross and 
Blue Shield plans to expand the guidelines, so far only 8 have 
been set: coronary artery bypass grafts, angioplasty, 
laparoscopic gallbladder removals, new red blood cell 
transfusions, breast-conserving lumpectomies, and 3 oncology 
guidelines. 
STRENGTHS AND WEAKNESSES OF DISEASE MANAGEMENT 8 
The diagnosis-specific approach can achieve high levels of validity 
when the standards are developed and applied properly. The 
approach can also yield a continuous score for the quality of care 
provided, ranging from superior to grossly substandard. This attribute 
allows for the identification of marginally suboptimal care as well as 
that which is frankly substandard. Some of the other approaches to 
be discussed below tend to focus on a fairly narrow range of 
substandard care and lack the sensitivity to detect the marginally 
suboptimal. 
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The disadvantage of the diagnosis-specific approach is that it is 
costly, both to develop the criteria and to apply them. Thus, the 
diagnosis-specific approach tends to focus on a relatively small 
number of diagnostic categories. Kessner et al, however, attempted 
to illustrate how a limited set of diagnoses or "tracer conditions" 
could serve as a adequate proxy for a much broader range of care 
given by a provider. If an investigator's goal is to liSe tracer 
conditions to provide a broad assessment of the quality of a given 
institution, facility, or even a health care system, the tracers must be 
carefully chosen to provide the maximum coverage and impact. To 
make a general assessment of a facility, the investigator may prefer 
to select as tracers a sample of conditions which are relatively 
common, for which there are well-established standards, and for 
which failure to adhere to standards has fairly severe consequences. 
A final feature of the diagnosis-specific approach which can be both 
an advantage and a disadvantage is that it focuses primarily on 
process. This focus has the advantage of allowing the investigator to 
make more detailed judgments about quality that possible with other 
methods to be described primarily because it allow and in-depth 
examination of the treatment decisions made throughout an episode 
of care. However, as with process measures in general, it is often 
difficult to quantify the clinical impact of deviations from the 
established standards. Almost all cases fail to meet at least one of 
the standards. It is difficult, however, to tell in an absolute sense 
how serious the failure is in terms of actual or potential harm to the 
patient. 
As a result of these considerations, the primary uses of the diagnosis-
specific approach are for focused review (i.e., review which is 
targeted on known or potential problem areas) and research. The 
method may be particularly suited to ongoing use in a clinical setting 
over time, for example, for use by a hospital's quality assurance 
department or by a medical school in evaluating the effectiveness of 
its clinical training programs. The clinical specificity of the 
information gleaned in the review makes the method particularly 
applicable to the monitoring and correcting of individual practitioner 
performance. It is not, however, a realistic approach for wide scale 
monitoring. 
12 
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A. Key Capabilities 
Managing the disease, not the components of cost, is among 
the key capabilities now required. Most care management 
strategies are focused on managing the total cost of-each slice 
of the health care pie, such as hospital days, doctors' visits, 
pharmacy and diagnostics. Each episode of care becomes a 
transaction: a cost unit to be managed. Price and utilization 
control are the answers to all questions. In fact, this greatly 
constrains the potential for managing the real unit of cost: the 
disease. A disease management approach views an episode of 
care as a point on the continuum of a patient with a specific 
set of health care resource needs. 
Instead of disregarding what the system knows about the 
patient and the disease, the disease management approach 
encourages doctors and care managers to anticipate the 
management of the case. It enables physicians to make the 
appropriate choices around the key junctures in the clinical 
process that drive the quality and cost of care. Focusing the 
medical management initiatives to achieve more consistent care 
delivery at these critical junctures offers much greater potential 
benefit than focusing the energy of the medical director's office 
on eliminating the last day of hospital care. Key elements of 
such a strategy are to assemble and record the knowledge 
about what it costs to restore health at different stages of a 
disease and how patient health outcomes correlate with 
comprehensive treatment programs and to evaluate the cost-
effectiveness of various preventive measures. 
For example, while a cost-component view of asthma might 
dictate against early referrals to specialists or constrain 
formulary choices for specific drugs, a disease management 
approach would find that for severe asthmatics encouraging 
early referrals to a pulmonary specialist, use of inhaled steroids 
and/or an expensive new drug could generate significant 
savings by avoiding costly emergency room visits later, while 
also improving the patient's quality of life. Some studies 
suggest that a comprehensive disease management strategy for 
asthma could save as much as 25 % of the total cost for 
moderate to severe asthmatics. 
13 
More managed care organizations are adopting disease 
management as the centerpiece of their strategies to cut cost 
and improve quality. United Health Care, a national managed 
care organization based in Minneapolis, is developing a portfolio 
of programs ranging from its maternity care program to the 
United Resource Network to facilitate the access of its 
members to donor organs when needed. John Deere Health 
Care is collaborating with the Mayo Clinic to develop a broad 
set of disease-specific strategies to be implemented at both 
institutions. The disease range from heart disease to 
depression. 
As with any fundamental redesign of the value creation 
process, the organizational requirements for coordinated 
disease management are stringent. Successful execution 
requires intensive involvement by the members, employers, 
physicians and system managers. It also requires 
unprecedented levels of cooperation with providers on 
incentives, network design, information flow and behavioral 
expectations. At a minimum, care managers must be highly 
integrated with the network designers. 
Collaborative product design is a second key capability. 
Heightened competition in managed care will make it necessary 
for companies to respond to consumer demand for specialized 
services within standardized product offerings or benefit 
coverage. Whether consumers buy their health care directly or 
through large government or employer coalitions, there is a 
opportunity to tailor services to their specific needs. This 
ensures that a product addresses a current market need and 
allows for more effective sharing of a high cost investment or 
underwriting health risk. 
Health Partners, formerly known as Group Care, in Minneapolis, 
for example, surveyed the employees of the 14 employers in 
the Business Health Care Action Group coalition to assess their 
health status and lifestyle habits. It then used this information 
to develop its wellness programs and to identify the disease for 
which it would create care management protocols. The health 
system made sure it managed the specific diseases and 
conditions it customers cared about most. It also helped them 
avoid the costs of managing complexity by narrowing the range 
of products it offered employers. 
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Partnership with providers is a third critical capability. 
Networks of physicians and hospitals are beginning to compete 
directly with managed care companies by building integrated 
systems with the ability to assume risk, develop effective 
managed care programs and process their own claims. To 
keep providers out of the ranks of the competition, managed 
care needs to find ways to work with them more effectively. A 
vaguely antagonistic relationship now exists largely because of 
mistrust and a lack of common understanding by the provider 
groups and the managers of managed care systems. Providers 
suspect that managers focus primarily on costs and sacrifice 
quality of care by second-guessing the decisions of care givers, 
who are closest to the patient. Managers assume that 
providers generally treat patients without regard to cost. Even 
staff-model HMOs often have difficulty getting the 
administrative/business and medical management hierarchies to 
work effectively on care-management issues. 
The challenge for managed care is to establish a mechanism 
that encourages providers to deliver quality care while being 
aware of the cost of the treatments they choose. But 
empowering physician decision-making raises concerns about 
losing control. A solution is to ask the physicians themselves 
to become partners with insurers or managed care 
organizations in creating the guidelines and network platforms 
for managing their panel of patients, while sharing the benefits 
that accrue from giving the patient the best, most cost-
effective treatment. This can translate into new types of risk-
sharing agreements supported by meaningful information on 
physician performance. U.S. Healthcare recently modified its 
physician compensation programs to reflect improved 
performance measured in specific ways. An alternative is to 
reduce the stress and day-to-day annoyance in office practice 
and managed care. Several companies are exploring ways to 
enhance the efficiency of the physician's back office through 
better office management and connection with the local 
administrative offices. 
The final capability, an enabler more that a cross-functional 
process, is providing integrated information management. 
Health care delivery programs must make information 
technology work for quality health care as well as it does for 
efficient transaction processing. Many managed care 
companies originally focused their information technology 
capability on building a financial control system - collecting 
15 
B. 
premiums and supporting the component management and 
referral management strategy. Few companies have been able 
to realize the enormous opportunities to increase member and 
provider satisfaction, manage administrative and medical costs, 
and support quality-of-care initiatives through effective 
deployment of information technology. Unfortunately, several 
companies, including a few Blue Cross and BIHe Shield 
organizations, have almost broken the bank trying to get there. 
At the heart of this key capability platform is the need to link 
appropriate constituencies with the key database-adding 
functionality to meet the needs of each user. Within the 
managed care organization, this includes making common 
clinical and administrative data accessible to clinicians, 
marketing, underwriting and network designers. At a minimum, 
a medical system application might have a tickler file for 
physicians, reminding them that certain patients must be called 
in for follow-up care at appropriate times when additional 
outcomes information and patient satisfaction data also can be 
collected. This information could be used to create new care 
management tools or refine existing ones. 
A more visionary system might provide access to high-quality, 
up-to-date medical data to help clinicians diagnose, treat and 
follow up with patients more effectively. A doctor diagnosing a 
patient, for instance, could call up an agreed-upon treatment 
protocol on a clinical workstation and get the latest data on the 
trade-offs among various medical, surgical and drug 
interventions. He or she also might get information about the 
outcomes associated with each treatment combination, in 
terms of patient health status and satisfaction with the care 
process. 
Disease Management Themes 4 
1 . Although there is not widespread use of disease 
management techniques in the industry presently, the 
systematic focus on specific diseases is intuitively sound, 
is being conducted by several leading-edge healthcare 
delivery systems, and is supported by specific cost 
reduction and quality improvement evidence and study. 
2. The focus on specific diseases is intuitively sound due to 
specific study evidence which identifies that 5 % of 
patients account for 70% of the costs associated with 
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certain diseases with the majority of costs associated 
with out-of-control cases. 
3. Disease management approaches have largely been an 
outgrowth of quality improvement efforts where 
population-based approaches to clinical quality 
improvement have led to focus on high volume health 
problems and chronic conditions. 
4. The industry leaders as well as others that are involved 
in disease management approaches are utilizing COi 
approaches/models to conduct improvement efforts. 
5. Experts suggest that integrated delivery systems offer 
the most viable model to conduct effective disease 
management since these systems bring medical and cost 
data together most efficiently. More open models require 
a more intense investment in information systems, but 
preserve greater choice among providers for patients. 
6. Disease management can be a basis for integration 
inasmuch as the high volume disease problems of 
populations/customers can dictate which "disease 
specific" network providers are required. 
7. The pharmaceutical industry through its Pharmacy 
Benefit Management (PMBs) are in collaboration with 
managed care organizations and managed care "specialty 
services" organizations (Value Health, GMIS, etc.) on 
disease management as an added value proposition. 
8. Disease management approaches may run counter to the 
role of PCPs as most chronic cases may be best suited 
for "specialty care networks". 
9. There are a variety of disease management models which 
includes "disease carveouts" through capitation, case-
specific nurse disease management, and triage to disease 
specialist who becomes the disease PCP. 
10. Key capabilities in managed care start with managing the 
disease, not the components of cost. Price and 
utilization control can constrain the potential for 
managing the real unit of cost - the disease. The disease 
management approach anticipates the management of 
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the case. As an example, some studies suggest that a 
comprehensive disease management strategy for asthma 
could save as much as 25 % of the total cost for 
moderate to severe asthmatics. Care managers must be 
highly integrated with the network designers. Other 
capabilities include: collaborative product design; 
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